• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FXYD5 的低表达逆转了上皮性卵巢癌细胞的顺铂耐药性。

Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.

机构信息

Department of Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Department of Gynecology, People's Hospital of Tang County, Baoding, Hebei, China.

出版信息

Histol Histopathol. 2021 May;36(5):535-545. doi: 10.14670/HH-18-310. Epub 2021 Feb 11.

DOI:10.14670/HH-18-310
PMID:33570156
Abstract

OBJECTIVE

To investigate the effect of the downregulation of FXYD domain-containing ion transport regulator 5 (FXYD5) on the cisplatin resistance (CisR) of epithelial ovarian cancer (EOC) cells.

METHODS

A2780-CisR and SKOV3-CisR cells were obtained through repeated administrations of different cisplatin concentrations, and the half-maximal inhibition concentration (IC50) was calculated by MTT assays. After transfection with FXYD5 siRNA-1 and FXYD5 siRNA-2, the IC50 values of the A2780-CisR and SKOV3-CisR cells were also detected by the MTT method. Cell proliferation, migration, invasion and apoptosis were evaluated through 5-ethynyl-2'-deoxyuridine (EdU) DNA synthesis, wound healing, Transwell invasion and Annexin-V-FITC/PI dual-staining assays, respectively. qRT-PCR and Western blotting were conducted to detect mRNA and protein expression.

RESULTS

Compared with the sensitive parental cells, the A2780-CisR and SKOV3-CisR cells had increased IC50 and FXYD5 expression. FXYD5 siRNA reduced the IC50 value of cisplatin in the A2780-CisR and SKOV3-CisR cells and decreased the expression of ABCG2 (BCRP) and ABCB1 (MDR1). In addition, FXYD5 inhibition reduced the invasion and migration of the A2780-CisR and SKOV3-CisR cells, with upregulation of E-cadherin and downregulation of Snail and Vimentin. Both FXYD5 siRNA-1 and FXYD5 siRNA-2 inhibited the proliferation and promoted the apoptosis of the A2780-CisR and SKOV3-CisR cells with reduced Ki-67 and increased caspase-3.

CONCLUSION

FXYD5 downregulation may reduce the invasion, migration and EMT formation of EOC cells to increase their sensitivity to cisplatin chemotherapy by inhibiting cell proliferation and promoting cell apoptosis.

摘要

目的

研究 FXYD 结构域含离子转运调节剂 5(FXYD5)下调对上皮性卵巢癌(EOC)细胞顺铂耐药(CisR)的影响。

方法

通过反复给予不同浓度顺铂,获得 A2780-CisR 和 SKOV3-CisR 细胞,并通过 MTT 测定计算半抑制浓度(IC50)。用 FXYD5 siRNA-1 和 FXYD5 siRNA-2 转染后,通过 MTT 法检测 A2780-CisR 和 SKOV3-CisR 细胞的 IC50 值。通过 5-乙炔基-2'-脱氧尿苷(EdU)DNA 合成、划痕愈合、Transwell 侵袭和 Annexin-V-FITC/PI 双重染色试验分别评估细胞增殖、迁移、侵袭和凋亡。通过 qRT-PCR 和 Western blot 检测 mRNA 和蛋白表达。

结果

与敏感亲本细胞相比,A2780-CisR 和 SKOV3-CisR 细胞的 IC50 和 FXYD5 表达增加。FXYD5 siRNA 降低了 A2780-CisR 和 SKOV3-CisR 细胞中顺铂的 IC50 值,并降低了 ABCG2(BCRP)和 ABCB1(MDR1)的表达。此外,FXYD5 抑制降低了 A2780-CisR 和 SKOV3-CisR 细胞的侵袭和迁移,上调了 E-钙黏蛋白,下调了 Snail 和波形蛋白。FXYD5 siRNA-1 和 FXYD5 siRNA-2 均抑制了 A2780-CisR 和 SKOV3-CisR 细胞的增殖,促进了细胞凋亡,Ki-67 减少,caspase-3 增加。

结论

FXYD5 下调可能通过抑制细胞增殖和促进细胞凋亡,减少 EOC 细胞的侵袭、迁移和 EMT 形成,从而提高其对顺铂化疗的敏感性。

相似文献

1
Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.FXYD5 的低表达逆转了上皮性卵巢癌细胞的顺铂耐药性。
Histol Histopathol. 2021 May;36(5):535-545. doi: 10.14670/HH-18-310. Epub 2021 Feb 11.
2
Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.通过靶向C-Jun恢复卵巢癌中的miR-139-5p可逆转顺铂耐药性。
Cell Physiol Biochem. 2018;51(1):129-141. doi: 10.1159/000495169. Epub 2018 Nov 15.
3
Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.冬凌草甲素通过诱导细胞凋亡和抑制基质金属蛋白酶表达,有效逆转人卵巢癌细胞对顺铂的耐药性。
Mol Med Rep. 2016 Apr;13(4):3342-8. doi: 10.3892/mmr.2016.4897. Epub 2016 Feb 16.
4
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.HPIP通过激活PI3K/AKT信号通路促进卵巢癌细胞上皮-间质转化和顺铂耐药。
Cell Oncol (Dordr). 2017 Apr;40(2):133-144. doi: 10.1007/s13402-016-0308-2. Epub 2016 Dec 30.
5
Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).叉头框蛋白C2促进顺铂耐药人卵巢癌细胞系(SKOV3/CDDP)的上皮-间质转化、迁移和侵袭。
Cell Physiol Biochem. 2016;39(3):1098-110. doi: 10.1159/000447818. Epub 2016 Aug 26.
6
A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.FXYD5/TGF-β/SMAD 正反馈环驱动上皮间质转化,促进卵巢癌的生长和转移。
Int J Oncol. 2020 Jan;56(1):301-314. doi: 10.3892/ijo.2019.4911. Epub 2019 Nov 13.
7
[Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].[二氢叶酸还原酶基因表达上调在上皮性卵巢癌顺铂耐药中的作用]
Zhonghua Fu Chan Ke Za Zhi. 2015 Nov;50(11):854-60.
8
Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression.富含转移特性且 Twist 表达增加的卵巢癌细胞系中获得性顺铂耐药性的建立。
Int J Mol Sci. 2020 Oct 15;21(20):7613. doi: 10.3390/ijms21207613.
9
MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells.多药耐药基因1和多药耐药基因3与卵巢癌细胞对顺铂的耐药性
J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):721-4. doi: 10.1007/s11596-007-0627-7.
10
Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.小窝蛋白-1通过Notch-1/Akt/NF-κB途径靶向细胞凋亡,介导顺铂耐药卵巢癌细胞的化疗耐药。
Oncol Rep. 2015 Dec;34(6):3256-63. doi: 10.3892/or.2015.4320.

引用本文的文献

1
FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation.FXYD5通过调节上皮-间质转化来调控胃癌细胞的转移和耐药性。
Cancer Gene Ther. 2025 Mar;32(3):318-326. doi: 10.1038/s41417-025-00878-9. Epub 2025 Feb 21.
2
FXYD6 is transcriptionally activated by KLF10 to suppress the aggressiveness of gastric cancer cells.FXYD6被KLF10转录激活,以抑制胃癌细胞的侵袭性。
Cytotechnology. 2025 Apr;77(2):48. doi: 10.1007/s10616-025-00710-0. Epub 2025 Jan 25.
3
Circ_0001068 accelerates the development of ovarian cancer by promoting FXYD5 expression through inhibiting mir-149-5p activity.

本文引用的文献

1
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.Ki-67 指数为 55%可区分两组具有不同预后的支气管肺纯和复合大细胞神经内分泌癌。
Neuroendocrinology. 2021;111(5):475-489. doi: 10.1159/000508376. Epub 2020 May 4.
2
Elucidating the multi-drug resistance mechanism of Enterococcus faecalis V583: A gene interaction network analysis.阐明粪肠球菌 V583 的多药耐药机制:基因相互作用网络分析。
Gene. 2020 Jul 20;748:144704. doi: 10.1016/j.gene.2020.144704. Epub 2020 Apr 24.
3
Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid.
Circ_0001068通过抑制mir-149-5p活性促进FXYD5表达,从而加速卵巢癌的发展。
Discov Oncol. 2024 Nov 12;15(1):648. doi: 10.1007/s12672-024-01497-w.
4
Enhanced ZNF521 expression induces an aggressive phenotype in human ovarian carcinoma cell lines.增强 ZNF521 的表达可诱导人卵巢癌细胞系呈现侵袭表型。
PLoS One. 2022 Oct 3;17(10):e0274785. doi: 10.1371/journal.pone.0274785. eCollection 2022.
5
Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts.α-倒捻子素和顺铂作为卵巢癌细胞与成纤维细胞外泌体相互作用调节剂。
Int J Mol Sci. 2022 Aug 10;23(16):8913. doi: 10.3390/ijms23168913.
木犀草素与溶质载体转运蛋白和 ATP 结合盒转运蛋白的相互作用:该黄酮类化合物的药物转运体特征。
Chem Biol Interact. 2020 Jun 1;324:109097. doi: 10.1016/j.cbi.2020.109097. Epub 2020 Apr 16.
4
Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition.环氧化酶-2 通过调节上皮间质转化促进卵巢癌细胞迁移和顺铂耐药性。
J Zhejiang Univ Sci B. 2020;21(4):315-326. doi: 10.1631/jzus.B1900445.
5
Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.伊维菌素通过抑制 Akt/mTOR 信号通路增强顺铂在卵巢上皮性癌细胞系和体内的抗肿瘤活性。
Am J Med Sci. 2020 Feb;359(2):123-129. doi: 10.1016/j.amjms.2019.11.001. Epub 2019 Nov 9.
6
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.FXYD5/去黏附素,一种子宫内膜癌肌层浸润和侵袭性的生物标志物:其与转化生长因子-β1和核因子-κB信号通路的关系
Front Oncol. 2019 Dec 6;9:1306. doi: 10.3389/fonc.2019.01306. eCollection 2019.
7
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.FXYD5(黏附连接蛋白 5)上调预示着高级别浆液性卵巢癌患者的生存时间更短,并提示铂类耐药。
Br J Cancer. 2019 Oct;121(7):584-592. doi: 10.1038/s41416-019-0553-z. Epub 2019 Aug 22.
8
Downregulation of BAG3 attenuates cisplatin resistance by inhibiting autophagy in human epithelial ovarian cancer cells.BAG3的下调通过抑制人上皮性卵巢癌细胞的自噬来减弱顺铂耐药性。
Oncol Lett. 2019 Aug;18(2):1969-1978. doi: 10.3892/ol.2019.10494. Epub 2019 Jun 19.
9
Calcium homeostasis in cisplatin resistant epithelial ovarian cancer.顺铂耐药上皮性卵巢癌中的钙稳态
Gen Physiol Biophys. 2019 Jul;38(4):353-363. doi: 10.4149/gpb_2019013. Epub 2019 Jun 20.
10
Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer.多药方案吉西他滨、5-氟尿嘧啶、伊立替康、顺铂、贝伐珠单抗、多西他赛和环磷酰胺(GFIP/BDC)用于复发的上皮性卵巢癌、输卵管癌和原发性腹膜癌的大量预处理。
J Ovarian Res. 2019 Apr 25;12(1):36. doi: 10.1186/s13048-019-0506-4.